Eyal Gibor

A.D.O. Group Ltd. is a holding company, which engages in the provision of investment services. It operates through the Yielding Residential Real Estate and Condo Apartments for Sale segments. The Yielding Residential Real Estate segment is involved in the management, rental, development, and maintenance of residential and commercial properties. The Condo Apartments for Sale segment includes all aspects related to the preparation and execution of the sale of condo apartments, which includes the conversion of the apartments into separate condo apartments for sale, its maintenance, and temporary rental of apartments until the sale. The company was founded on January 30, 1987 and is headquartered in Ramat Gan, Israel.

Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel.

Euro Globe Overseas 1968 Ltd. is a development stage company. It intends to acquire Kyorii Ltd., which develops, manufactures and markets medical devices. The company was founded in 1969 and is headquartered in Ramat Gan, Israel.